Anti-PD-1 antibody decreases tumour-infiltrating regulatory T cells

BACKGROUND: There are many types of therapies for cancer. In these days, immunotherapies, especially immune checkpoint inhibitors, are focused on. Though many types of immune checkpoint inhibitors are there, the difference of effect and its mechanism are unclear. Some reports suggest the response ra...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Yoshida, Kazushige, Okamoto, Masanori, Sasaki, Jun, Kuroda, Chika, Ishida, Haruka, Ueda, Katsuya, Ideta, Hirokazu, Kamanaka, Takayuki, Sobajima, Atsushi, Takizawa, Takashi, Tanaka, Manabu, Aoki, Kaoru, Uemura, Takeshi, Kato, Hiroyuki, Haniu, Hisao, Saito, Naoto
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6950856/
https://ncbi.nlm.nih.gov/pubmed/31914969
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-6499-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados